metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology On what to do where prodigal daughters might be increasing?
Información de la revista
Vol. 19. Núm. 5.
Páginas 578 (septiembre - octubre 2020)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 19. Núm. 5.
Páginas 578 (septiembre - octubre 2020)
Letter to the Editor
Open Access
On what to do where prodigal daughters might be increasing?
Visitas
1173
Lucia Lisseth Vazquez-Villagrana, Hugo Laviada-Molinaa, Michael Prelipb, Nina Mendez-Domingueza,
Autor para correspondencia
nmendez@marista.edu.mx

Corresponding author at:
a Escuela de Medicina, Universidad Marista de Merida, Merida, Yucatan, Mexico
b Fielding School of Public Health, University of Califormia, Los Angeles, USA
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Texto completo

Recently we read the article entitled Alcohol and the Liver: The Return of the Prodigal Son[1] and wished to reply some of the unanswered questions with emphasis in the epidemiological and preventive aspects of alcohol-related liver disease (ALD) by providing the sociodemographic context of Yucatan, one of the 31 states of Mexico.

The complex environment in Yucatan might involve certain factors that Campollo [1] associated with ALD. According to the National Institute of Statistics and Geography (INEGI), in 2016, 487 deaths occurred due to alcoholic cirrhosis (ALC) in the state of Yucatan. ALC deaths in Mexico (nationwide) occurred among women at age 60, but in Yucatan women died at a mean age of 51 (Fig. 1).

Fig. 1.

Age at death among men and women who died due to Alcoholic Liver Cirrhosis nationwide in Mexico and Yucatan during 2016 (N=10,471).

(0.11MB).
Source: Open access mortality database retrieved from INEGI.

In Yucatan, Mayan and mestizo ethnicity represent over one-third of the inhabitants, and evidence suggests that genetic factors may inflict certain proneness to obesity and metabolic syndrome (MS) [2]. MS is common in ALC and potentially may interact as an overlapping factor contributing to the severity of ALD and vice versa, suggesting the co-existence of ALD and non-alcoholic fatty liver disease (NAFLD) [3]. This synergy may be valid for other pathologic mechanisms such as infection, autoimmunity or drug-related liver damage [4].

Yucatan isaccording to the latest National Survey of Addiction (Encodat), among the regions with the highest alcohol consumption in the previous years, with 46.2% prevalence of which 26.1% are women; this percentage is greater than the national female average of alcohol consumption. Nationally, women represent 8.99% of all ALC-related mortality cases, but according to INEGI in Yucatan, women represent 11.76%.

As stated in Campollo's opinion, women are more susceptible to alcohol effects and this phenomenon becomes even more important when understanding its clinical and epidemiological implications which are not restricted to ALD. Alcohol consumption in women can facilitate violent affective relations [5] and, during pregnancy, it correlates with adverse neonatal outcomes. Alcohol drinking prevention campaigns in the US have now turned to target the Hispanic female population, as a result of the identification of an increase in their alcohol consumption [6].

Perhaps an answer to Campollo's question shall we focus our efforts on preventing ALD is – Yes, we certainly should! and particularly among women from environments where excessive alcohol consumption may be socially normalized, such as in Yucatan. So, let's prevent from having a prodigal daughter!

References
[1]
O. Campollo.
Alcohol and the liver: the return of the prodigal son.
Ann Hepatol, 18 (2018), pp. 6-10
[2]
L. González-Herrera, J. Zavala-Castro, C. Ayala-Cáceres, G. Perez-Mendoza, M.J. López-González, D. Pinto-Escalante, et al.
Genetic variation of FTO: rs1421085 T>C, rs8057044 G>A, rs9939609 T>A, and copy number (CNV) in Mexican Mayan school-aged children with obesity/overweight and with normal weight.
Am J Hum Biol, 31 (2019), pp. e23192
[3]
M. Mehta, S. Satsangi, A. Duseja, S. Taneja, R.K. Dhiman, Y. Chawla.
Can alcoholic liver disease and nonalcoholic fatty liver disease co-exist?.
J Clin Exp Hepatol, 7 (2017), pp. 121-126
[4]
G. Brar, H. Tsukamoto.
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science.
J Gastroenterol, 54 (2019), pp. 218-225
[5]
T.L. Hughes, S.C. Wilsnack, L.W. Kantor.
The influence of gender and sexual orientation on alcohol use and alcohol-related problems: toward a global perspective.
Alcohol Res, 38 (2016), pp. 121-132
[6]
D. Glik, M. Prelip, A. Myerson, K. Eilers.
Fetal alcohol syndrome prevention using community-based narrowcasting campaigns.
Health Promot Pract, 9 (2018), pp. 93-103
Copyright © 2019. Fundación Clínica Médica Sur, A.C.
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos